The 11th Annual Diabetes Symposium of Wisconsin
Our symposium is a two day program with the specific purpose of increasing education and knowledge of all aspects of diabetes clinical practice and research. This symposium consists of medical lectures and workshops given by healthcare professionals (not all MD's), investigators and patients on topics related to Diabetes Updates. The major format used is a series of thematic talks by recognized health professional and are all followed by question and answer sessions along with feedback. There will also be a panel of physicians who will present case discussions and then open the floor to the audience for a Question and Answer Session.
Physicians, Family Care Physicians,
Adult Endocrinologists, Pediatric Endocrinologists, Fellows,
Residents, Medical Students, Dietitians, Physician Assistants,
Nurses and Nurse Practitioners
The target audience has been identified not only from the educational aims,
but also from the previous meetings after post-meeting evaluations.
- Improve diabetes and obesity care by identifying and expounding evidence-based advances in management.
- Analyze the areas that are at the outer limits of current knowledge of diabetes and obesity and define our limitations.
- Improve management and knowledge of drugs and therapy for diabetes and obesity, using well-controlled trial data.
- Gain further knowledge about the pathophysiological processes involved in diabetes and obesity.
- Increase awareness of the patient perspective of diabetes and obesity care.
Thursday, May 10th, 2018
7:00 am - 8:00 am Registration
8:00 am - 8:10 am Introduction/Welcome
8:10 am - 8:50 am Rudolph Leibel, MD - Molecular Physiolgy of the Weight-Reduced State: Why
Weight Loss is Hard to Sustain
8:50 am - 9:30 am Srividya Kidambi, MD - Role of Adiposity Distribution in Health and Disease
9:30 am - 10:10 am Aimee Welsh, MD - Cardiovascular Disease Risk in Patients with Diabetes Mellitus:
Insights from the Updated Hypertension and Cholesterol Management Guidelines
10:10 am - 10:25 am Break
10:25 am - 10:45 am Q & A: Case Discussion and Audience Response Session
10:45 am - 11:25 am Jonathon W. Senefeld, PhD Candidate - Exercise: The Panacea for Diabetes
11:25 am - 12:05 pm Rudolph Leibel, MD - Stem Cell-Based Approaches to the Biology of Diabetes and
12:05 pm - 1:05 pm Lunch
1:05 pm - 1:25 pm Q & A: Case Discussion and Audience Response Session
1:25 pm - 2:05 pm David Serreze, PhD - To B or not to B: The Role of B-lymphocytes in T cell Mediated
Autoimmune Type 1 Diabetes (TID)
2:05 pm - 2:45 pm Susanne Cabrera, MD - Disease Heterogeneity in Type 1 Diabetes
2:45 pm - 3:25 pm Erin Newkirk, PharmD, CDE - Advancements in Diabetes Technology: A Focus on
Continuous Glucose Monitoring
3:25 pm - 3:40 pm Break
3:40 pm - 4:00 pm Q & A: Case Discussion and Audience Response Session
4:00 pm - 4:40 pm Tim Wysocki, PhD, A.B.P.P. - Research on Family-Centered Care for Pediatric Type 1
Friday, May 11th, 2018
7:00 am - 8:00 am Registration and Breakfast
8:00 am - 8:10 am Introduction/Welcome
8:10 am - 8:50 am Robert Blank, MD, PhD - The Year in Review
8:50 am - 9:30 am Steven Magill, MD, PhD - New Medications to Treat Diabetes in 2018
9:30 am - 9:50 am Q & A: Case Discussion and Audience Response Session
9:50 am - 10:05 am Break
10:05 am - 10:25 am Q & A: Case Discussion and Audience Response Session
10:25 am - 11:05 am Mukoso Ozieh, MD - Diabetic Kidney Disease: What You Need to Know
11:05 am - 11:45 am Leonard Egede, MD - Current State of Racial/Ethnic Disparities in Diabetes
11:45 am - 12:45 pm Lunch
12:45 pm - 1:05 pm Q & A: Case Discussion and Audience Response Session
1:05 pm - 1:45 pm Jeffrey Gonzalez, MD - Depression in Type 2 Diabetes: Emerging Evidence on Role of
1:45 pm - 2:25 pm Paul Knudson, MD - Inpatient Management of Diabetes Mellitus
2:25 pm - 3:05 pm Jennifer Richter, APNP - Barriers to Diabetes Management in the Primary Care
3:05 pm - 3:20 pm Break
3:20 pm - 4:00 pm Carlos Mendez, MD - Diabetes Management in the Elderly
4:00 pm - 4:40 pm Hashim Zaibak, PharmD, CDE & Dimmy Sokhal,PharmD - Role of Pharmacist in
In accordance with the ACCME® standard for Commercial Support Number 6, all in control of content disclosed any relevant financial relationships. The following in control of content had no relevant financial relationships to disclose.
- Susanne M. Cabrera, MD (Speaker)
- Lindsey Cushman, PA-C (Planning Committee)
- Alan David, MD (Planning Committee)
- Rosanna V. Fiallo-Scharer, MD (Planning Committee)
- Gina George, PA-C (Planning Committee)
- Jeffrey Gonzalez, PhD (Speaker)
- Martin J. Hessner, PhD (Planning Committee)
- Susan Hjelsand (Planning Committee)
- Srividya Kidambi, MD, MS (Planning Committee & Speaker)
- Paul Knudson, MD (Speaker)
- Rudolph Leibel, MD (Speaker)
- Steven B. Magill, MD, PhD (Speaker)
- Carlos E. Mendez, MD, FACP (Speaker)
- Erin Newkirk, PharmD, CDE (Speaker)
- Mukoso Ozieh, MD, MSCR (Speaker)
- Carolyn Raasch, APNP (Planning Committee)
- Jennifer Richter, MSN, APNP-BC (Speaker)
- Jonathon W. Senefeld, PhD Candidate (Speaker)
- David Serreze, PhD (Speaker)
- Dimmy Sokhal (Speaker)
- Aimee Welsh, MD (Speaker)
- Tim Wysocki, PhD, A.B.P.P. (Speaker)
- Hashim Zaibak, PharmD (Speaker)
In accordance with the ACCME® standards for Commercial Support Number 6, all in control of content disclosed any relevant financial relationships. These relationships were reviewed via the MCW conflict of interest resolution process and resolved:
|Robert D. Blank, MD, PhD (Activity Director & Speaker)||Amgen, Bristol Myers Squibb, Novo-Nordisk, Radius Health, Ultragenyx|
|Robert D. Blank, MD, PhD (Activity Director & Speaker)||McGraw Hill, UpToDate||Commissioned Educational Material|
|Leonard E. Egede, MD, MS (Planning Committee & Speaker)||Novo-Nordisk||Advisory Board Member|
ACCME Accreditation Statement:
The Medical College of Wisconsin is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
AMA Credit Designation Statement:
The Medical College of Wisconsin designates this for a maximum of 13.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Hours of Participation for Allied Health Care Professionals:
The Medical College of Wisconsin designates this activity for up to 13.5 hours of participation for continuing education for allied health professionals.
AAFP Credit Designation:
This Live activity, The 11th Annual Diabetes Symposium of Wisconsin, with a beginning date of 05/10/2018, has been reviewed and is acceptable for up to 14.00 Prescribed credit(s) by the American Academy of Family Physicians. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
AAFP Prescribed credit is accepted by the American Medical Association as equivalent to AMA PRA Category 1 Credit(s)™ towards the AMA Physician's Recognition Award. When applying for the AMA PRA, Prescribed credit earned must be reported as Prescribed, not as Category 1.
- 13.50 AAFPAAFP credit.
- 13.50 AMA PRA Category 1 Credit(s)™AMA PRA Category 1 Credit(s)™
- 13.50 Hours of ParticipationHours of Participation credit.
|Physicians (full course)||$215.00|
|Allied Health Care Professionals (full course)||$215.00|
|Residents/Fellows/Students* (full course)||$215.00|
*Residents, Fellows, Students and Medical College of Wisconsin Advanced Practice Providers who specialize in Endocrinology and Pediatric Endocrinology may attend this conference at no cost however, on-line registration is required.
To obtain your complementary registration fee instructions, prior to checking out, contact Debby Warpechowski at 414-955-6724 or via email at email@example.com.
Cancellations dated seven or more business days prior to the start of the course will be fully refunded. Cancellations received less than seven days before the course will be refunded at 50%. Cancellations received after the course begins will not be refunded. In the unlikely event the symposium is cancelled, the Medical College of Wisconsin is not responsible for airfare, hotel or other costs incurred by participants.